Clearmind Medicine Inc. Closes US2.4 Million Registered Direct and Private Placement
| CMND Stock | USD 1.49 0.04 2.76% |
About 55% of Clearmind Medicine's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Clearmind Medicine Common suggests that some traders are interested. The current market sentiment, together with Clearmind Medicine's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearmind Medicine Common stock news signals to limit their universe of possible portfolio assets.
Clearmind |
TEL AVIV, ISRAEL VANCOUVER, CANADA, Jan. 16, 2024 -- Clearmind Medicine Inc. , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the closing of its previously announced definitive agreements with institutional investors for the purchase and sale of Common Shares and Pre-Funded Warrants in a registered direct offering. In a concurrent privat
Read at finance.yahoo.com
 |
Clearmind Medicine Fundamental Analysis
We analyze Clearmind Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearmind Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearmind Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Clearmind Medicine is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Clearmind Medicine Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearmind Medicine stock to make a market-neutral strategy. Peer analysis of Clearmind Medicine could also be used in its relative valuation, which is a method of valuing Clearmind Medicine by comparing valuation metrics with similar companies.
Peers
Clearmind Medicine Related Equities
| IMMX | Immix Biopharma | 3.54 | ||||
| UNCY | Unicycive Therapeutics | 1.61 | ||||
| VRAX | Virax Biolabs | 3.27 | ||||
| WINT | Windtree Therapeutics | 4.76 | ||||
| REVB | Revelation Biosciences | 8.57 | ||||
| COEP | Coeptis Therapeutics | 9.81 | ||||
| NBY | NovaBay Pharmaceuticals | 12.35 | ||||
| SONN | Sonnet Biotherapeutics | 14.50 | ||||
| CDIO | Cardio Diagnostics | 20.63 | ||||
| QNRX | Quoin Pharmaceuticals | 30.51 |
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |